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Abstract 32 
Hypothermic machine perfusion (HMP) and static cold storage (SCS) are the 33 
two methods used to preserve deceased donor kidneys prior to transplant. 34 
This study seeks to characterise the metabolic profile of HMP and SCS 35 
porcine kidneys in a cardiac death donor model.  36 
 37 
Twenty kidneys were cold flushed and stored for two hours following retrieval. 38 
Paired kidneys then underwent 24 hours of HMP or SCS or served as time 39 
zero controls. Metabolite quantification in both storage fluid and kidney tissue 40 
was performed using one dimensional 1H-NMR spectroscopy. For each 41 
metabolite, the net gain for each storage modality was determined by 42 
comparing the total amount in each closed system (i.e. total amount in 43 
storage fluid and kidney combined) compared with controls. 26 metabolites 44 
were included for analysis.  45 
 46 
Total system metabolite quantities following HMP or SCS were greater for 14 47 
compared with controls (all p<0.05). In addition to metabolic differences with 48 
control kidneys, the net metabolic gain during HMP was greater than SCS for 49 
8 metabolites (all p<0.05). These included metabolites related to central 50 
metabolism (lactate, glutamate, aspartate, fumarate and acetate).  51 
 52 
The metabolic environments of both perfusion fluid and the kidney tissue are 53 
strikingly different between SCS and HMP systems in this animal model. The 54 
total amount of central metabolites such as lactate and glutamate observed in 55 
the HMP kidney system suggests a greater degree of de novo metabolic 56 
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activity than in the SCS system. Maintenance of central metabolic pathways 57 
may contribute to the clinical benefits of HMP. 58 
 59 
  60 
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Introduction 61 
 62 
Hypothermic Machine Perfusion (HMP) and Static Cold Storage (SCS) are the 63 
two methods of kidney preservation that are used widely in clinical practice 64 
during the time period between organ retrieval and implantation [16]. A key 65 
concept for both preservation modalities is that cellular metabolism, and 66 
therefore cellular metabolic requirements, are minimised in these hypothermic 67 
conditions and the rate of metabolism reported to be about 5-8% at 68 
temperatures below 4°C [29] with a similar decrease in oxygen requirement 69 
[1].  70 
 71 
The superiority of HMP over SCS is well documented [4,17,22,23,27] but the 72 
mechanisms by which this occurs are not clear. Improvement in flow 73 
dynamics, with fall in the intra-renal resistance is likely to be one factor but the 74 
additional metabolic support derived from the circulation of nutrient-containing 75 
perfusion fluid may also help preserve organ function and have a beneficial 76 
effect [7,30]. 77 
  78 
Metabolomic analyses of preservation fluid during HMP using 1D-1H-79 
NMR (One-dimensional proton nuclear magnetic resonance) spectroscopy, by 80 
groups including our own, have demonstrated this to be reproducible and 81 
highly specific for metabolite identification and quantification [2,10,24]. 82 
However, surprisingly, to our knowledge there are no studies that have sought 83 
to compare the metabolomic profiles, or metabolome, of HMP and SCS 84 
kidneys. 85 
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  86 
Porcine kidneys are widely used in transplantation studies owing to their 87 
similar physiological and anatomical properties to human organs [9,11]. In 88 
addition, the metabolic profiles during periods of HMP for porcine and human 89 
kidneys are comparable [24], with a correlation between metabolite profiles 90 
during storage and post transplant outcome [2]. For HMP preserved human 91 
kidneys, the metabolic profile from perfusates of immediate graft function 92 
kidneys differs from those with delayed function [10] and reinforces the 93 
concept that significant metabolism occurs during HMP and that metabolism 94 
reflects functional outcome. 95 
 96 
The aims of this study were twofold. Firstly, to determine the distribution of 97 
metabolites between the two different compartments (fluid and tissue) during 98 
the organ preservation period. Secondly, to determine the total amount of 99 
each metabolite within HMP and SCS kidneys systems after 24 hours of 100 
organ storage and through comparison with control kidneys, the metabolic 101 
changes that occur.  102 
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Methods 103 
 104 
Animal Research 105 
 106 
Abattoir/slaughterhouse pig kidneys (F.A. Gill, Wolverhampton, UK) were 107 
used and no animals were sacrificed solely for the purposes of this study, 108 
negating any need for ethical board approval. Experiments were performed on 109 
22-26 week old male ‘bacon weight’ pigs, weighing 80-85kg. All experiments 110 
were performed following the principles of laboratory animal care according to 111 
NIH standards. Animals were sacrificed by electrical stunning and 112 
exsanguination. Initial organ preservation was performed following organ 113 
retrieval and occurred within 14 minutes of death, replicating deceased 114 
cardiac death (DCD) donor conditions. Kidneys were cold flushed (4°C) with 115 
1L SPS-1 (UW) solution at a pressure of 100mmHg. Organs were then stored 116 
at 4°C in SPS-1 for 2 hours to replicate the clinical period of organ 117 
transportation. 118 
 119 
Experimental groups 120 
 121 
Paired kidneys were randomly allocated to receive either HMP or SCS for 24 122 
hours. HMP kidneys were perfused with 1L of KPS-1 using the LifePort 123 
Kidney Transporter 1.0 (Organ Recovery Systems, Chicago, IL). (Perfusion 124 
pressure 30mmHg). SCS Kidneys were submerged in 1L of fresh chilled SPS-125 
1 solution with a surrounding ice bath. Preservation fluid was sampled for 126 
each kidney at baseline and 2, 4, 8, 12, 18, and 24 hours. After 24 hours, 127 
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organs were rapidly dissected and tissue samples (1cm3 sections) flash frozen 128 
and stored (-80°C). All experiments were performed in a cold room (4°C) to 129 
ensure consistency.  130 
 131 
 132 
Control kidneys 133 
 134 
To ascertain metabolism during SCS or HMP storage conditions, baseline 135 
values prior to storage conditions were needed (time 0). Large volume tissue 136 
sampling precludes effective organ perfusion and therefore ‘Control kidneys’ 137 
were used to establish baseline metabolite levels. These were (n=6) flushed 138 
and cold transported in identical fashion to experimental kidneys and tissue 139 
samples obtained as described above (i.e. not subjected to 24hrs of SCS or 140 
HMP). 141 
 142 
Sample processing and metabolite quantification 143 
 144 
NMR samples were prepared from storage fluid by mixing 150 µL of 400 mM 145 
(pH 7.0) phosphate buffer containing 2 mM DSS (4,4-dimethyl-4-silapentane-146 
1-sulfonic acid) and 8mM imidazole with 390 µL of each fluid sample and 60 147 
µL of deuterium oxide (D2O) to reach a final phosphate buffer concentration 148 
of 100 mM and a final DSS concentration of 500 µM. After mixing, the 600 µL 149 
samples were pipetted into 5mm NMR tubes, sonicated and centrifuged. 150 
Technical replicates of samples (x3) were prepared for each timepoint.  151 
 152 
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For cell extract studies, 500mg of renal cortex was manually cryo-153 
homogenised in liquid nitrogen. 5.1ml of both methanol (-80°C) and 154 
chloroform was added to the powdered tissue and samples diluted with 155 
4.65ml of dH20 at 4°C. Samples were centrifuged to separate into polar and 156 
non-polar layers and 1.5ml of the upper polar layer was dispensed into a 157 
cryovial and dried. Three technical replicates were performed for each tissue 158 
sample. Dried polar residue was then dissolved in 390µL of dH20 and 210 µL 159 
of buffer solution as described above.  160 
 161 
The protocol used for 1H-NMR analysis has been described previously 162 
[10,24]. Briefly, this entailed processing on a Bruker AVII 500 MHz 163 
spectrometer, acquisition of one dimensional spectra and then metabolite 164 
identification and quantification using Matlab based ‘Metabolab’ software [18] 165 
and Chenomx 8.1 (ChenomxInc) software respectively. Metabolites were 166 
deemed to be present if they exhibited non-ambiguous spectral patterns or 167 
their presence deemed biologically plausible and confirmed on ultra 168 
performance liquid chromatography mass spectrometry. Any metabolites that 169 
were present in different concentrations in the SCS and HMP fluid (e.g. 170 
glucose, gluconate, mannitol, adenine, adenosine etc.) were excluded from 171 
comparative analysis. Metabolite quantifications were corrected to allow for 172 
sample dilution with sample buffer. When determining concentrations of 173 
metabolites using Chenomx, the researchers were blind to the storage group. 174 
Quantification of the total amount of metabolite in the storage fluid, tissue and 175 
total system was calculated based upon the weight of the kidney at time of 176 
sample acquisition and final volume of storage fluid.  177 
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 178 
Statistical analysis 179 
For each timepoint, three results were obtained (technical replicates) and the 180 
median value used. For comparison of SCS and HMP conditions, analysis 181 
was performed using Wilcoxon paired signed rank test (two tailed) as one 182 
kidney from each pair was subjected to each condition and normality was not 183 
consistent on prior analysis. When comparing SCS or HMP with control 184 
kidneys, Mann-Whitney u test (two tailed) was used, as these were non-185 
paired samples. Data were reported as median concentrations and 186 
interquartile (IQ) range. All analysis was performed using GraphPad Prism 187 
version 6.00 for Mac OS X, GraphPad Software, La Jolla California USA, with 188 
p<0.05 deemed to be indicative of statistical significance.  189 
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Results 190 
 191 
Metabolic optimisation of cadaveric kidneys is a potential target to improve the 192 
function of kidneys for transplantation. This study seeks to establish the 193 
degree of metabolism, if any, that occurs in the two widely used methods of 194 
kidney organ storage prior to transplantation (HMP and SCS). 195 
  196 
The total quantity of each metabolite after 24 hours of either HMP or SCS was 197 
calculated using 1H-NMR methods and compared with control organs to 198 
determine the net metabolic change during each storage method.  199 
 200 
We found evidence of metabolite production for both storage modalities with 201 
14 metabolites present in significantly greater quantities in the HMP or SCS 202 
system compared with controls (all p<0.05) (table 1)(Fig 1, Fig 1(Suppl)). 203 
There were significantly more metabolites with a net increase in the HMP 204 
system (13/14) compared with the SCS system (7/14) (p=0.033). 205 
 206 
Table 1. Total amount of metabolite present in each of the storage modalities 207 
at time zero (controls) or after 24 hours of preservation (SCS or HMP). Data 208 
reported as Median (Interquartile Range), unless stated otherwise. Statistical 209 
test: Ψ Mann-Whitney u test (two tailed) #Wilcoxon paired signed rank test 210 
(two tailed). *Significant at p<0.05.  211 
 212 
Fig. 1. Metabolites significantly elevated in the HMP system compared with 213 
both SCS and control kidneys. Metabolite levels represent total amounts 214 
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(mmol) in the storage fluid, kidney tissue and entire system for porcine 215 
kidneys after 24hrs of HMP or SCS or time zero controls. Highly significant 216 
(**p<0.01) and significant (*p<0.05) differences between HMP system versus 217 
both controls and SCS kidneys.  218 
 219 
 220 
Eight of the metabolites were significantly elevated in the HMP system 221 
compared with both the control and SCS systems (all p<0.05), indicating a 222 
greater degree of metabolite production. These included lactate, glutamate, 223 
aspartate, fumarate, acetate, myo-inisitol, niacinamide and formate (Fig 1).  224 
 225 
Despite the additional 24 hours of organ preservation, albeit in static 226 
conditions, the amount of lactate in the SCS system was comparable to 227 
controls (1.37 vs 1.11mmol p=0.138). However the amount in the HMP 228 
system (2.13mmol) was almost twice the amount of either controls or SCS 229 
systems (p=0.002 and p=0.031). However, despite greater amounts overall, 230 
the amount present in the HMP tissue (0.76mmol) was actually lower than 231 
SCS tissue (1.14mmol) or control tissue (1.11mmol) (p= 0.031 and p=0.002 232 
respectively), reflective of lower intracellular concentrations for HMP kidneys.  233 
 234 
The distribution of metabolites between the extracellular storage fluid and 235 
tissue samples for both storage conditions are detailed in table 2. As 236 
expected, there were greater quantities of metabolites in the circulating HMP 237 
fluid compared with the static conditions of SCS at most time-points. After 24 238 
hours, the total amount of metabolite in the perfusate for the HMP kidneys 239 
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was significantly greater than the SCS group for (21/26 = 80.8%) of 240 
metabolites. Whilst concentrations rose most rapidly in the first 2 hours of 241 
perfusion and therefore may be in part due a metabolite washout 242 
phenomenon, there was an increase in most metabolites over sequential 243 
timepoints as would be expected with on-going production (fig 2a-c). 244 
 245 
Table 2. Metabolites present in tissue and storage fluid in HMP or SCS kidney 246 
systems at 24 hours. Data reported as Median (Interquartile Range), unless 247 
stated otherwise. Statistical test: #Wilcoxon paired signed rank test (two 248 
tailed). *Significant at p<0.05. 249 
Fig. 2. Concentration of metabolites in the storage fluid of SCS and HMP 250 
kidneys over 24 hour time period for four example metabolites. Values plotted 251 
as median (interquartile range). 252 
 253 
 254 
Reduced glutathione is a constituent of both KPS-1 (used in HMP) and SPS-1 255 
(used in SCS) fluids at equal concentrations. Whilst this remained at stable in 256 
the SCS environment, the glutathione was clearly consumed by the HMP 257 
group and after 8 hours concentrations were 17.6 fold higher in the SCS fluid 258 
(1.60mM vs. 0.091mM, p=0.001) (fig 2d).  Despite apparent organ uptake of 259 
reduced glutathione, there was no evidence of this in the tissue samples from 260 
either group.  261 
 262 
 263 
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Discussion 265 
 266 
The aim of this study was to determine any metabolic differences between the 267 
two clinically used methods of organ storage in this animal model.  268 
 269 
Whilst the calculation of the total amount of metabolite within the system does 270 
rely on several assumptions (complete metabolite extraction from tissue and 271 
metabolite homogeneity within tissue), we felt this was imperative to draw 272 
meaningful comparison between groups and enables the calculation of net 273 
metabolite production/consumption in these two closed systems (HMP and 274 
SCS).   275 
 276 
Although the storage fluid used in each experimental group differs (most 277 
notably absence of glucose in the SCS fluid) and therefore caution should be 278 
exercised in attributing any differences merely to the parameters of storage 279 
(i.e. HMP or SCS), this study was designed to assess metabolism during the 280 
two clinically used organ preservation techniques, not merely the storage 281 
modality in isolation.  282 
 283 
This study clearly demonstrates the presence of major central metabolites 284 
such as lactate, glutamate, fumarate, aspartate and acetate at greater levels 285 
in the HMP system compared with both controls and SCS (fig. 2). This 286 
strongly suggests that these metabolites are being produced during HMP. 287 
Furthermore, the accumulation of these metabolites into the circulating 288 
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perfusion fluid demonstrates effective homeostatic mechanisms are active to 289 
prevent over accumulation within the local cellular environment.  290 
 291 
The list of metabolites reported in this study is not exhaustive and is a 292 
limitation of this study. Some interesting substrates (eg glucose) were 293 
excluded as this is only present in one of the storage fluids (KPS-1). For 294 
others the 1D 1H NMR spectral pattern is either ambiguous or can be hidden 295 
under more domineering peaks from other compounds.  296 
 297 
The increased total lactate in the HMP system is likely to reflect increased 298 
glycolysis in the HMP model. Although new glycolytic activity of the glucose 299 
within the HMP fluid is one likely contributor, this is unlikely to the singular 300 
cause. This is supported by evidence that the HMP fluid glucose 301 
concentrations did not decrease during the study period and replicates 302 
findings from previous human studies [10]. However conversion of a 303 
proportion of perfusion fluid glucose into lactate through glycolytic pathways 304 
has been corroborated by work demonstrating activity of these pathways 305 
using 13C labelled glucose tracers[25]. 306 
 307 
The net gain of glutamate, fumarate, aspartate and acetate during HMP is 308 
also intriguing. Whilst identification of responsible metabolic pathways is 309 
difficult to ascribe solely with 1H NMR studies, one explanation could be 310 
increased oxygen dependent tricarboxylic acid (TCA) cycle activity. Although 311 
uniform upregulation of TCA intermediates would support this theory, as 312 
discussed, many are not easily identifiable using 1H NMR methods[6] and are 313 
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rarely found in equipoise even in vivo [14]. Several (13C) NMR studies have 314 
reported glutamate as a valid marker of TCA activity [3,5,20].  315 
 316 
For some metabolites, the total system amounts for HMP and SCS kidneys 317 
were comparable to the controls, suggesting that either de novo production 318 
does not occur during the 24 hour preservation or that consumption mirrors 319 
production (table 1 supplementary). However, for metabolites with similar total 320 
amounts, the compartment in which they were located varied per metabolite. 321 
Some metabolites were entirely contained within the HMP kidney tissue (e.g. 322 
ADP, AMP, NAD+) and presumably in the intracellular compartment. Other 323 
metabolites were evident in both the tissue and storage fluid but at higher 324 
concentrations in the HMP fluid. These discrepancies in metabolite location 325 
further highlight that cellular transport processes are active in this 326 
environment but that movement of metabolites into the extracellular fluid is not 327 
indiscriminate.   328 
 329 
Reduced glutathione is a constituent of the preservation fluid KPS-1 and is 330 
thought to play a role in the removal of Reactive Oxygen Species (ROS) 331 
generated during metabolism [19] In contrast to the SCS kidney, there is a 332 
rapid decrease in the concentration of glutathione in the preservation fluid of 333 
HMP stored kidneys and is about 5% of the SCS values after 8 hours (fig 1c.). 334 
The rate of glutathione depletion observed in this study is similar to a 335 
previously reported animal model [28] and is likely to reflect cellular uptake of 336 
this protective antioxidant. Interestingly, glutathione concentration remained 337 
relatively constant in the SCS kidney group. This further reinforces the 338 
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concept that HMP exerts its beneficial effects, at least in part, by providing 339 
access to the cellular components of the kidney during perfusion. Absence of 340 
reduced glutathione in tissue demonstrates that not only is this protective 341 
antioxidant readily absorbed by the kidney during perfusion but that even after 342 
a few hours it is not longer available in the reduced state. 343 
 344 
Although the number of organs in each experimental group is small (n=7), it is 345 
comparable to other porcine kidney transplant reports [8,12,15,21,26,30]. To 346 
improve validity, samples were processed in triplicate at each timepoint and 347 
over 250 NMR spectra were analysed. One strength of this study is that the 348 
kidneys stored by HMP or SCS were paired, i.e. from the same pig, thus 349 
minimising any metabolic differences arising from polymorphism in cellular 350 
mediators of porcine metabolism. Although this approach does not provide 351 
functional outcome information for the preserved organ, previous studies have 352 
demonstrated good function for otherwise healthy porcine organs stored by 353 
either SCS or HMP for similar time periods[2,8,13,15,21,26].  354 
 355 
This study demonstrates that in a porcine model, the distribution and amounts 356 
of metabolites vary significantly with the storage method (HMP or SCS). The 357 
net gain of many central metabolites during HMP conditions further supports 358 
the notion that significant metabolism occurs during HMP and this may 359 
contribute to the beneficial role of machine perfusion. 360 
 361 
 362 
  363 
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 468 
 469 
Fig. 1. (suppl) Metabolites with comparable total amounts between SCS and 470 
HMP systems but significantly elevated compared with controls. Metabolite 471 
levels represent total amounts (mmol) in the storage fluid, kidney tissue and 472 
entire system for porcine kidneys after 24hrs of HMP or SCS or time zero 473 
controls. Highly significant (**p<0.01) and significant (*p<0.05) differences 474 
between HMP and SCS systems versus controls. 475 
Fig. 2. (suppl) Chemical shift used for metabolic quantification. Localised 476 
spectral plots for metabolites of interest with shaded figures illustrating 477 
metabolite quantification via best-fit analysis using Chenomx metabolite 478 
database.  479 
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 Storage Modality p-Values 
      Control System 
(mmol) 
SCS System 
(mmol) 
HMP System 
(mmol) 
Control vs 
SCS
 Ψ
 
 
Control vs 
HMP
 Ψ
 
 
SCS vs 
HMP
 #
 
Glutamate 1.54 (1.12- 1.84) 1.38 (1.11- 1.66) 3.97 (3.69- 4.71) 0.731 0.002* 0.031* 
Myoinositol 1.18 (1.16- 1.19) 1.29 (1.01- 1.52) 2.16 (1.85- 2.41) 0.731 0.002* 0.031* 
Lactate 1.11 (0.976- 1.23) 1.38 (1- 1.75) 2.13 (1.67- 2.71) 0.138 0.002* 0.031* 
Hypoxanthine 0.454 (0.356- 
0.515) 
0.710 (0.641- 0.762) 1.05 (0.909- 1.17) 0.001* 0.002* 0.156 
Formate 0.442 (0.274-  
0.638) 
0.643 (0.589- 0.779) 0.842 (0.750- 0.943) 0.101 0.004* 0.031* 
Acetate 0.210 (0.206- 
0.212) 
0.296 (0.253-0.301) 0.552 (0.494-0.654) 0.234 0.041* 0.031* 
Alanine 0.302 (0.243- 
0.360) 
0.486 (0.339- 0.499) 0.501 (0.368- 0.558) 0.035* 0.015* 0.313 
Succinate 0.283 (0.267- 
0.297) 
0.462 (0.312- 0.52) 0.434 (0.307- 0.541) 0.001* 0.015* 0.844 
Inosine 0.588 (0.561- 
0.628) 
1.08 (0.885- 1.12) 0.185 (0.146- 0.233) 0.001* 0.002* 0.031* 
Aspartate 0.114 (0.104- 
0.118) 
0.107 (0.0879- 0.11) 0.165 (0.140- 0.215) 0.234 0.041* 0.031* 
Leucine 0.0476 (0.0441-
0.0517) 
0.0667 (0.0513-
0.0820) 
0.0693 (0.0495-
0.0773) 
0.014* 0.026* 0.688 
Niacinamide 0.0196 (0.0181- 
0.0207) 
0.0289 (0.0243- 
0.0319) 
0.0490 (0.0420- 
0.0557) 
0.001* 0.002* 0.031* 
Tyrosine 0.0262 (0.0217- 
0.0302) 
0.0434 (0.0339- 
0.0462) 
0.0387 (0.0332- 
0.0431) 
0.001* 0.013* 0.438 
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Fumarate 0.00412 (0.00339- 
0.00418) 
0.00308 (0.00145- 
0.00348) 
0.0133 (0.0077- 
0.0212) 
0.064 0.002* 0.031* 
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 Storage Total storage fluid amount 
(mmol) 
p-value
#
 Total kidney tissue amount 
(mmol) 
p-Value
#
 
Glutamate 
 
SCS 0.0812 (0.125- 0.155) 0.0312* 0.952 (1.26- 1.58) 0.6875 
HMP 2.72 (2.75- 2.89)  0.94 (1.24- 1.68)  
Myoinositol 
 
SCS 0.316 (0.399- 0.879) 0.0625 0.596 (0.676- 0.853) 0.5625 
HMP 1.05 (1.25- 1.38)  0.653 (0.816- 1.3)  
Lactate  
 
SCS 0.153 (0.205- 0.245) 0.0312* 0.89 (1.14- 1.59) 0.0312* 
HMP 1.15 (1.38- 1.82)  0.521 (0.755- 0.895)  
Hypoxanthine  
 
SCS 0.294 (0.328- 0.404) 0.0312* 0.289 (0.407- 0.424) 0.0625 
HMP 0.705 (0.781- 0.867)  0.189 (0.258- 0.31)  
Formate 
 
SCS 0.132 (0.136- 0.186) 0.4375 0.434 (0.486- 0.545)  0.0312* 
HMP 0.151 (0.16- 0.169)  0.688 (0.599- 0.774)  
Acetate 
 
SCS 0.073 (0.0808- 0.0912) 0.0312* 0.167 (0.201- 0.229) 0.0312* 
HMP 0.239 (0.257- 0.331)  0.252 (0.289- 0.344)  
Alanine  
 
SCS 0.0465 (0.0643- 0.0815) 0.0312* 0.303 (0.415- 0.435) 0.0312* 
HMP 0.253 (0.306- 0.358)  0.116 (0.187- 0.207)  
Succinate 
 
SCS 0.0104 (0.0155- 0.0184) 0.0312* 0.298 (0.446- 0.498) 0.0312* 
HMP 0.104 (0.131- 0.208)  0.203 (0.294- 0.347)  
Inosine 
 
SCS 0.703 (0.852- 0.961) 0.0312* 0.145 (0.182- 0.201) 0.0312* 
HMP 0.0877 (0.108- 0.128)  0.058 (0.0723- 0.109)  
Aspartate SCS - 0.0312* 0.0879 (0.107- 0.11) 0.3125 
HMP 0.039 (0.0452- 0.0682)  0.0874 (0.115- 0.155)  
Leucine 
 
SCS 0.00442 (0.00506- 0.00761) 0.0312* 0.0486 (0.0591- 0.0775) 0.0312* 
HMP 0.0285 (0.038- 0.0468)  0.0222 (0.0304- 0.0318)  
Niacinamide  
 
SCS - 0.0312* 0.0243 (0.0289- 0.0319) 0.0938 
HMP 0.0221 (0.028- 0.0282)  0.0194 (0.0221- 0.0278)  
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Tyrosine SCS 0.00336 (0.0071- 0.00843) 0.0312* 0.0306 (0.0371- 0.0391) 0.0312* 
HMP 0.0197 (0.0228- 0.0276)  0.0112 (0.0143- 0.0171)  
Fumarate  
 
SCS - 0.0312* 0.00145 (0.00308- 0.00348) 0.0312* 
HMP 0.00456 (0.00737- 0.00895)  0.00314 (0.00574- 0.0126)  
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Metabolic differences between cold stored and machine perfused porcine 
kidneys: A 1H-NMR based study. 
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